Family Medicine Doctors in Avon, OH Accepting Medicare

5 Family Medicine doctors found. Showing 1 - 5

Charles M Butrey, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1480 Center Rd, Suite A, Avon, OH 44011 Phone: 440-937-4600    Fax: 440-937-4605

Mohammed A Jayber, DO Family Medicine - Adult Medicine Medicare: Accepting Medicare Assignments Practice Location: 2217 Wisteria Way, Avon, OH 44011 Phone: 440-934-7080    Fax: 440-934-0818

John W Escolas, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1480 Center Rd, Suite A, Avon, OH 44011 Phone: 440-934-4600    Fax: 440-937-4605

Miss Smriti Gupta, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 33300 Cleveland Clinic Blvd # 2-148, Avon, OH 44011 Phone: 440-695-5000

Kenneth J Carbone, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1480 Center Rd, Suite A, Avon, OH 44011 Phone: 440-937-4600    Fax: 440-937-4605

News Archive

Controversy over recent breast cancer screening guidelines discussed

The controversy over recent breast cancer screening guidelines offers an opportunity to engage individual patients in an informed discussion of the importance of evidence-based clinical efficacy assessments in contributing to better care decisions, Donna Sweet, MD, MACP today told the Subcommittee on Health of the House Energy and Commerce Committee. Dr. Sweet testified at a hearing, Breast Cancer Screening Recommendations, on behalf of the American College of Physicians (ACP).

Shire to enter European ADHD market with acquisition of EQUASYM IR and XL

Shire plc has announced that it has signed an agreement with UCB to acquire the worldwide rights to EQUASYM IR and XL (methylphenidate hydrochloride) (excluding the USA, Canada and Barbados) used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

Imaxio's pro-immunogenic technology used in tuberculosis vaccine phase I clinical study

Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The trial is being conducted by the Jenner Institute at Oxford University, England.

Spacelabs Healthcare introduces XPREZZON patient monitoring solution

Spacelabs Healthcare, which decades ago pioneered medical telemetry to monitor the vital signs of orbiting astronauts, today announced the launch of XPREZZON, a patient monitoring solution that delivers innovative technology and design to shape the new age of care for clinicians and patients alike.

Read more Medical News

› Verified 5 days ago